Source: Virtual Congress 2021 – COPD pharmacology: from basic science to real-world data



Rating:

Share or cite this content

Citations should be made in the following way:
J. Kim (Seoul, Republic of Korea), N. Kim (Seoul, Republic of Korea), C. Shon (Seoul, Republic of Korea), J. Huh (Seoul, Republic of Korea), K. Han (Seoul, Republic of Korea), K. Kim (Suwon, Republic of Korea), S. Shin (Seoul, Republic of Korea), H. Park (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea). The therapeutic potential of PD-1/PD-L1 blockade in smoking exposed emphysema. 2948

Member's Comments

No comment yet.

Related content which might interest you: PDE4 inhibition prevents corticosteroid-resistant lung inflammation induced by cigarette smoke exposure in mice Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury Year: 2009 Therapeutic neutralization of the matrikine PGP suppresses the development of lung emphysema in cigarette smoke exposed mice Source: International Congress 2016 – Mechanisms of disease Year: 2016 A role of mTOR in cigarette smoke-induced corticosteroid insensitivity Source: Annual Congress 2012 - Cellular signalling mechanisms in the airways Year: 2012 P2RX4 signalling enhances acute cigarette smoke-induced lung inflammation and chronic lung emphysema development Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets Year: 2019 Blocking IL-20 pathway limits the development of bacteria induced exacerbation in mice chronically exposed to cigarette smoke. Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018 Attenuation of lung inflammation and emphysema induced by cigarette smoke exposure in CXCR3 knockout mice Source: Annual Congress 2008 - Cell biology of asthma and COPD Year: 2008 Murine lung airway fibroblasts drive fibrosis through STAT4 signaling after cigarette smoke exposure Source: Annual Congress 2012 - The smoking gun in COPD biology Year: 2012 Distinct effect of IRAK-M on airway inflammation induced by exposure to LPS or cigarette smoking Source: International Congress 2017 – Cigarette smoke and particulate matter: basic science and clinical aspects Year: 2017 The effects of long-term smoking on pre-existing asthma in mice Source: Eur Respir J 2004; 24: Suppl. 48, 253s Year: 2004 The therapeutic effects of zafirlukast on COPD induced pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 415s Year: 2001 Role of ß2-adrenergic receptor in cigarette smoke-induced COPD in mice Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 Th17 cytokines: novel potential therapeutic targets for COPD pathogenesis and exacerbations Source: Eur Respir J, 50 (4) 1602434; 10.1183/13993003.02434-2016 Year: 2017 Adjuvant and anti-inflammatory properties of cigarette smoke in murine models of allergic airways inflammation Source: Annual Congress 2008 - Understanding allergic airway inflammation with the help of animal models Year: 2008 IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation. Source: International Congress 2018 – Novel drug targets for asthma and COPD Year: 2018 FPS-ZM1-induced blocking of RAGE alleviates elastase-induced emphysema development by preventing RAGE-DAMP-Nrf2 signaling Source: International Congress 2017 – From the bench: therapeutic approaches in COPD and emphysema Year: 2017 Mitochondria-targeted H2S suppresses and reverses cigarette smoke-induced inflammasome activity and lung injury in experimental COPD Source: ERS Lung Science Conference 2020 Year: 2020 Acute effect of passive cigarette smoking on airway inflammation Source: Eur Respir J 2005; 26: Suppl. 49, 129s Year: 2005 Effects of smoking on circulating and airway T-lymphocytes antigen expression in patients with COPD after radiation exposure Source: Eur Respir J 2003; 22: Suppl. 45, 550s Year: 2003 The influence of smoking and the lack of response to prednisolone on tissue-derived T-cells in COPD and severe asthma Source: Eur Respir J 2005; 26: Suppl. 49, 23s Year: 2005